Galapagos | Profitto Lordo Sulle Vendite



Gross Profit On Sales Cambiamento Data
argenx SE USD 837.21M 127.34M 2025-06
AstraZeneca USD 11.98B 637M 2025-06
Biogen USD 2.04B 238.8M 2025-06
Genmab DKK 673M 5.43B 2025-03
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
GRIFOLS EUR 743.8M 49.13M 2025-06
Hikma Pharmaceutical USD 692M 64M 2024-12
Incyte USD 1.14B 151.67M 2025-06
Merck EUR 3.03B 118M 2025-06
Neurocrine Biosciences USD 676.2M 112.8M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.74B 26M 2025-06
UCB EUR 2.46B 520M 2024-12
Vertex Pharmaceuticals USD 2.56B 150M 2025-06


Galapagos Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.